We Are Committed to Accessibility: YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg

We Are Committed to Accessibility

Dedicated to equal access for everything we have to offer

We are committed to providing a welcoming experience to any visitor to this website who may need improved accessibility.

Whether you’re using assistive technologies (screen reader, magnifier, voice recognition software, or switch technology, etc.) or want direct changes within the site itself, our aim is to make our site accessible to you.

We strive to ensure compliance with all Web Content Accessibility Guidelines (WCAG) and regularly test our site to ensure we are in line or exceed the standards.

Some of the ways we help provide you with the best experience

Site layout: We use appropriate headings, lists, paragraphs, and other formatting features so that guests can easily use the site with assistive technology

Contrast settings: The website is available in a dark mode to reduce eye strain

Text equivalents: People who are unable to see images or hear audio may need some form of a text equivalent to interact with our sites, which is why our graphics and media are fully accessible through alternative text, captions, or transcripts

Adjustable text: The text settings allow users to increase font sizes

Keyboard utility: The entire website can be accessed using a keyboard

Please call us at 1-833-EYEPOINT (1-833-393-7646)
with any questions or concerns.

Contact EyePoint

See more about YUTIQ

*People pictured are not real patients unless otherwise noted.

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ

YUTIQ may cause serious side effects, including:

Injection-related effects, steroid-related effects and movement of the implant.

Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.

You may experience temporary blurred vision. Do not drive or use machines until your vision clears.

The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.

If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite B300, Watertown, MA 02472

12/2022

US-YUT-2200116

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ